← FDA Drug Approvals (Drugs@FDA)
IPRATROPIUM BROMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2024-11-15
Drug application
- FDA Application #
ANDA219221- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IPRATROPIUM BROMIDE
- Generic name
- IPRATROPIUM BROMIDE
- Active ingredients
- IPRATROPIUM BROMIDE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2024-11-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown